Literature DB >> 24034070

Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management.

Giulio Fortuna1, Michael T Brennan.   

Abstract

Systemic lupus erythematosus is a chronic autoimmune disorder characterized by production of autoantibodies directed against nuclear and cytoplasmic antigens, affecting several organs. Although cause is largely unknown, pathophysiology is attributed to several factors. Clinically, this disorder is characterized by periods of remission and relapse and may present with various constitutional and organ-specific symptoms. Diagnosis is achieved via clinical findings and laboratory examinations. Therapies are based on disease activity and severity. General treatment considerations include sun protection, diet and nutrition, smoking cessation, exercise, and appropriate immunization, whereas organ-specific treatments include use of steroidal and nonsteroidal anti-inflammatory drugs, immunosuppressive agents, and biologic agents.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Epidemiology; Pathophysiology; Systemic lupus erythematous; Treatment

Mesh:

Substances:

Year:  2013        PMID: 24034070     DOI: 10.1016/j.cden.2013.06.003

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  33 in total

1.  APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus.

Authors:  Shideh Namazi; Nader Tajik; Vahid Ziaee; Maryam Sadr; Samaneh Soltani; Arezou Rezaei; Samaneh Zoghi; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-11-23       Impact factor: 2.980

Review 2.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

3.  Proteomics analysis of lysine crotonylation and 2-hydroxyisobutyrylation reveals significant features of systemic lupus erythematosus.

Authors:  Ting Xie; Jingjing Dong; Xianqing Zhou; Donge Tang; Dandan Li; Jiejing Chen; Yumei Chen; Huixuan Xu; Wen Xue; Dongzhou Liu; Xiaoping Hong; Fang Tang; Lianghong Yin; Yong Dai
Journal:  Clin Rheumatol       Date:  2022-08-08       Impact factor: 3.650

Review 4.  Use of granulocyte and monocyte adsorption apheresis in dermatology (Review).

Authors:  Laura Gnesotto; Guido Mioso; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2022-06-24       Impact factor: 2.751

5.  Expression of lncRNA NEAT1 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and its correlation with Th1/Th2 balance.

Authors:  Yanni Jiang; Yi Zhao; Xianming Mo
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

6.  Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.

Authors:  Yu-Qing Bao; Jun-Ping Wang; Zi-Wei Dai; Yan-Mei Mao; Jun Wu; Heng-Sheng Guo; Yuan-Rui Xia; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2019-09-16       Impact factor: 2.980

7.  Clinical characteristics and survival of patients with three major connective tissue diseases associated with pulmonary hypertension: A study from China.

Authors:  Jie Pan; Ling Lei; Cheng Zhao; Jing Wen; Fang Qin; Fei Dong
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

8.  A Systematic Review and Meta-analysis of Prevalence of Biopsy-Proven Lupus Nephritis.

Authors:  Hong Wang; Yi-le Ren; Jun Chang; Luo Gu; Ling-Yun Sun
Journal:  Arch Rheumatol       Date:  2017-07-25       Impact factor: 1.472

Review 9.  Treg: A Promising Immunotherapeutic Target in Oral Diseases.

Authors:  Yujing Zhang; Jihua Guo; Rong Jia
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 10.  Update on Biologic Therapies for Systemic Lupus Erythematosus.

Authors:  Helena Hiemisch Lobo Borba; Andreas Funke; Astrid Wiens; Shirley Ramos da Rosa Utiyama; Cássio Marques Perlin; Roberto Pontarolo
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.